Wei Xu

Shandong University — China

Medicine · Health Sciences

18h-index1.2kcitations104works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(10), Myeloproliferative Neoplasms: Diagnosis and Treatment(9), Aquaculture Nutrition and Growth(8), Lung Cancer Treatments and Mutations(7), Aquaculture disease management and microbiota(6)

Publications104 total

Hybrid symbolic regression for data-driven discovery: Governing dimensionless numbers in supercritical heat transfer
Energy·2025· 1 citedOpen Access
[Ultrasonic manifestations of splenic torsion in children].
PubMed·2025
Development of a TaqMan-based quantitative real-time PCR for the detection of Porcine circovirus type 3
Frontiers in Animal Science·2025Open Access
Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers
PLoS ONE·2025· 2 citedOpen Access
Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression
International Journal of Biological Sciences·2025· 9 citedOpen Access
Establishment of a TaqMan Quantitative Real-Time PCR for Detecting Lawsonia intracellularis
Veterinary Sciences·2025· 1 citedOpen Access
Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024
Human Vaccines & Immunotherapeutics·2025Open Access
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma
Biomarker Research·2025· 5 citedOpen Access
Hybrid Symbolic Regression for Data-Driven Discovery:Governing Dimensionless Numbers in Supercritical Heat Transfer
SSRN Electronic Journal·2025Open Access
Hybrid Symbolic Regression for Data-Driven Discovery: Governing Dimensionless Numbers in Supercritical Heat Transfer
SSRN Electronic Journal·2025Open Access
Construction and validation of a risk prediction model for depressive symptoms in a middle-aged and elderly arthritis population
World Journal of Orthopedics·2024Open Access
Immunogenicity and Safety of COVID-19 Vaccines in Patients with Lung Cancer: Results of a Systematic Review and Meta-Analysis
International Archives of Allergy and Immunology·2024· 1 cited
The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis
Cancer Cell International·2024· 10 citedOpen Access
Evaluation of albumin and lactate dehydrogenase in comparison with cytokeratin 19 fragments and neuron‐specific enolase as diagnostic biomarkers for non‐small cell lung cancer
iLABMED·2024Open Access
LE8 score in relation to cardiovascular disease and mortality in individuals with diabetes
European Heart Journal·2024Open Access
[Analysis of tumor regression after concurrent radiochemotherapy for locally advanced hypopharyngeal carcinoma].
PubMed·2024
Effectiveness and safety of segmentectomy vs. wedge resection for the treatment of patients with operable non‑small cell lung cancer: A meta‑analysis and systematic review
Oncology Letters·2024· 2 citedOpen Access
Survival and safety analysis of <scp>COVID</scp>‐19 vaccine in Chinese patients with <scp>non‐small</scp> cell lung cancer
Cancer Medicine·2024· 3 citedOpen Access
Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy
International Immunopharmacology·2024· 5 cited
Association Between Pretreatment Blood 25-Hydroxyvitamin D Level and Survival Outcomes in Patients With Clinically Localized Prostate Cancer: An Updated Meta-Analysis
Nutrition and Cancer·2024· 3 cited
page 1 of 6Next →

Frequent Co-authors

Qinghui Ai(8), Kangsen Mai(8), Guobin Fu(7), Sumei Lu(4), Lei Liu(4), Jingliang Wang(4), Fang Luan(4), Fengxian Jiang(4), Pancen Ran(4), Zhizhao Zhang(4), Liang Yu(3), Jiajun Tian(3), Jing Zhao(3), Na Sa(3), Shaoyu Wu(2), Guangfa Wang(2), Zhongqiu Liu(2), Jinjun Rao(2), Lin Lü(2), Yirong Ma(2)